U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Individuals Aged 18 and Over

Novavax’ vaccine is the first protein-based COVID-19 vaccine authorized in the U.S. Immunizations with the Novavax COVID-19 Vaccine, Adjuvanted as a primary series will begin upon product release and once a policy recommendation from the CDC is received Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, […]

thaipr.net

14 ก.ค. 65

Triastek announces research collaboration with Lilly to explore the application of 3D printing technology in oral delivery of drugs

On July 13, 2022, Triastek, Inc. (“Triastek”) announced a collaboration with Eli Lilly and Company (“Lilly”), a leading global pharmaceutical company, to leverage the advantages of 3D printing technology to enable precisely targeted and programmed release of drugs in specific regions of the GI tract. According to the agreement, the project will focus on the […]

thaipr.net

14 ก.ค. 65

Discovery Life Sciences Acquires AllCells

CREATES PREMIER GLOBAL PROVIDER OF CRITICAL STARTING MATERIALS AND ANALYTIC SERVICES TO ACCELERATE CELL AND GENE THERAPY APPLICATIONS Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, today announced its acquisition of AllCells®, a leading provider of clinical-grade (GMP-compliant) and Research Use Only (RUO) primary cell products.  With more than 30 years of collective cell and […]

thaipr.net

14 ก.ค. 65

Sport’s finest gather under the stars for the grand finale of the XXVI Fair Play Menarini International Award

Intense emotions and immense satisfaction were in the air during the final event of the XXVI Fair Play Menarini International Award. Yesterday evening, the award ceremony for the winners of the 2022 edition in Castiglion Fiorentino (Arezzo) drew an enjoyable end to this celebration of the values of sportsmanship, organised by the Fair Play Menarini Foundation. Ethics, loyalty and […]

thaipr.net

11 ก.ค. 65

JW Therapeutics Announces Initiation of Clinical Study of JWATM204 in Patients with Advanced Hepatocellular Carcinoma

JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the initiation of phase I clinical study of JWATM204 in patients with advanced hepatocellular carcinoma (HCC). Primary liver cancer (PLC), also known as liver carcinoma, is one of the common gastrointestinal malignancies worldwide. Approximately 85%-90% […]

thaipr.net

5 ก.ค. 65
1 66 67 68 69 70 128